GLAZER CAPITAL, LLC
Known title: 10% OwnerCIK: 0001076809
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Spectral AI to Present Burn Wound Imaging Data at ACS 2026. Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.
Transaction History
| REVB | ▼ Sell | Open Market | 611,541 | $6.2M | 9/23/2021 | View on chart |
| REVB | ▼ Sell | Open Market | 5 | $50 | 9/22/2021 | View on chart |
| REVB | ▼ Sell | Open Market | 43,000 | $433K | 9/21/2021 | View on chart |
| MDAI | ▼ Sell | Open Market | 1,125 | $11K | 5/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
REVB announces 1-for-7 reverse stock split effective Oct 20
Revelation Biosciences disclosed that its common stock will undergo a 1‑for‑7 reverse split, with the change taking effect on October 20. The split will combine seven existing shares into one, reducing the total share count and raising the per‑share price proportionally. This corporate action may help the stock meet price‑level requirements and could affect the share’s liquidity. The company’s other metrics remain unchanged.
REVB announces 1-for-7 reverse stock split effective Oct 20. Revelation Biosciences disclosed that its common stock will undergo a 1‑for‑7 reverse split, with the change taking effect on October 20. The split will combine seven existing shares into one, reducing the total share count and raising the per‑share price proportionally. This corporate action may help the stock meet price‑level requirements and could affect the share’s liquidity. The company’s other metrics remain unchanged.